Antioxidative and cardiovascular-protective activities of metabolite usnic acid and psoromic acid produced by lichen species Usnea complanata under submerged fermentation

Pharmaceutical Biology

Volumn 50, Issue 8, 2012, Pages 968-979

  Behera, Bhaskar C ^a   Mahadik, Nutan ^a   Morey, Mangesh ^a  

^a AGHARKAR RESEARCH INSTITUTE   (India)

Author keywords

Antioxidants; Enzyme inhibitory kinetics; Fermentation; Lichen culture

Indexed keywords

ACETIC ACID ETHYL ESTER; ACETONE; ALCOHOL; ANTIOXIDANT; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; METHANOL; PRAVASTATIN; PROTECTIVE AGENT; PSOROMIC ACID; UNCLASSIFIED DRUG; USNIC ACID;

ANTIOXIDANT ACTIVITY; ARTICLE; COMPETITIVE INHIBITION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG MECHANISM; ENZYME INHIBITION; FIBRINOLYSIS; HEART PROTECTION; HEAT SENSITIVITY; IC 50; IN VITRO STUDY; LIPID PEROXIDATION; NONHUMAN; SUBMERGED FERMENTATION; THALLUS; TISSUE CULTURE; USNEA; USNEA COMPLANATA;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIOXIDANTS; BENZOFURANS; BENZOXEPINS; BIOLOGICAL AGENTS; BIOREACTORS; CARBOXYLIC ACIDS; CULTURE MEDIA, CONDITIONED; DRUG DISCOVERY; ETHNOPHARMACOLOGY; FERMENTATION; FREE RADICAL SCAVENGERS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INDIA; KINETICS; LIPID PEROXIDATION; NITRIC OXIDE; OSMOLAR CONCENTRATION; SOLUBILITY; SOLVENTS; USNEA;

PARMELIACEAE; USNEA;

EID: 84863703090     PISSN: 13880209     EISSN: 17445116     Source Type: Journal    
DOI: 10.3109/13880209.2012.654396     Document Type: Article

References (50)

1. Ahmadjian V. (1967). Studies on lichenized fungi. Bryologist, 64, 168-179.
2. Antiplatelet Trial lists Collaboration. (1994). Collaborative overview of randomised trials of antiplatelet therapy prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. British Med J, 308, 81-106.
3. Astrup T, Mullertz S. (1952). The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys, 40, 346-351.
4. Behera BC, Verma N, Sonone A, Makhija U. (2005). Evaluation of antioxidant potential of the cultured mycobiont of a lichen Usnea ghattensis. Phytother Res, 19, 58-64.
5. Bischoff HW, Bold HC. (1963). Some soil algae from enchanted rock and related algal species. Phycological studies IV. Uni Texas Publ No. 6318, 1-95.
6. Bochar DA, Stauffacher CV, Rodwell VW. (1999). Investigation of the conserved lysines of Syrian hamster 3-hydroxy-3-methylglutaryl coenzyme A reductase. Biochemistry, 38, 15848-15852.
7. Boustie J, Grube M. (2005). Lichens-a promising source of bioactive secondary metabolites. Plant Genetic Res, 3, 273-287.
8. Brunauer G, Stocker-Worgotter E. (2005). Culture of lichen fungi for future production of biologically active compounds. Symbiosis, 38, 187-201.
9. Burton GW, Doba T, Gabe EJ, Hughes L, Lee FL, Prasad L, Ingold KU. (1985). Autoxidation of biological molecules. 4. Maximizing the antioxidant activity of phenols. J Am Chem Soc, 107, 7053-7065.
10. Culberson CF. (1972). Improved conditions and new data for the identification of lichen products by a standardized thin-layer chromatographic method. J Chromato, 72, 113-125.
11. Cushman DW, Cheung HS. (1971). Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem Pharmacol, 20, 1637-1648.
12. Davies MJ, Thomas AC. (1985). Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina. Br Heart J, 53, 363-373.
13. Deason TR, Bold HC. (1960). Phycological studies I. Exploratory studies of Texas soil algae. Univ of Texas Pub No. 60022.
14. Dembitsky VM. (1992). Lipids of lichens. Prog Lipid Res, 31, 373-397.
15. Dubois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. (1956). Colorimetric method for determination of sugars and related substances. Anal Chem, 28, 350-356.
16. Esimone CO, Grunwald T, Nworu CS, Kuate S, Proksch P, Uberla K. (2009). Broad spectrum antiviral fractions from the lichen Ramalina farinacea (L.) Ach. Chemotherapy, 55, 119-126.
17. Frimpong K, Rodwell VW. (1994). Catalysis by Syrian hamster 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Proposed roles of histidine 865, glutamate 558, and aspartate 766. J Biol Chem, 269, 11478-11483.
18. Halliwell B. (1997). Antioxidants and human disease: A general introduction. Nutr Rev, 55, S44-9; discussion S49.
19. Hamada N, Miyagawa H. (1995). Secondary metabolites from isolated lichen mycobionts cultured under different osmotic conditions. Lichenologist, 27, 201-205.
20. Hamada N. (1988). Depside from isolated mycobionts II. Lichenologist, 20, 294-295.
21. Hamada N. (1996). Induction of the production of lichen substances by non-metabolites. Bryologist, 99, 68-70.
22. Hanus LO, Temina M, Dembitsky V. (2008). Biodiversity of the chemical constituents in the epiphytic lichenized ascomycete Ramalina lacera grown on difference substrates Crataegus sinaicus, Pinus halepensis, and Quercus calliprinos. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub, 152, 203-208.
23. Hidalgo ME, Fernández E, Quilhot W, Lissi E. (1994). Antioxidant activity of depsides and depsidones. Phytochemistry, 37, 1585-1587.
24. Higuchi M, Miura Y, Boohene J, Kinoshita Y, Yamamoto Y, Yoshimura I, Yamada Y. (1993). Inhibition of tyrosine activity by cultured lichen tissues and bionts. Planta Med, 59, 253-255.
25. Honegger R, Kutasi V. (1990). Anthraquinone production in three aposymbiotically cultured teloschistalean lichen mycobionts. In: Nardon P, Gianinazzi-Pearson V, Grenier AM, Margulis M, Smith DC, eds. Endocytobiology IV. Paris: Institute National de la Recherche Agronomique, 175-178.
26. Huneck S. (1999). The significance of lichens and their metabolites. Naturwissenschaften, 86, 559-570.
27. Huneck S, Yoshimura I. (1996). Identification of lichen substances. Berlin: Springer-Verlag.
28. Kim HJ, Lee DH, Hwang YY, Lee KS, Lee JS. (2005). Characterization of beta-hydroxy-beta-methylglutaryl coenzyme A reductase inhibitor from Pueraria thunbergiana. J Agric Food Chem, 53, 5882-5888.
29. Kleemann R, Kooistra T. (2005). HMG-CoA reductase inhibitors: Effects on chronic subacute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr Drug Targets Cardiovasc Haematol Disord, 5, 441-453.
30. Kon Y, Iwashina T, Kashiwadani H, Wardlaw JD, Elix JA. (1997). A new dibenzofuron, isostrepsilic acid, produced by cultured mycobiont of the lichenized ascomycete Usnea orientalis. J Jap Bot, 72, 67-71.
31. Kowalski M, Hausner G, Piercey-Normore MD. (2011). Bioactivity of secondary metabolites and thallus extracts from lichen fungi. Mycosci, 52, 413-418.
32. Leuckert C, Ahmadjian V, Culberson CF, Johnson A. (1990). Xanthones and depsidones of the lichen Lecanora dispersa in nature and of its mycobionts in culture. Mycologia, 82, 370-378.
33. Lilly VG, Barnett HL. (1951). Physiology of Fungi. New York: McGraw-Hill.
34. Mahadik ND, Morey MV, Behera BC, Makhija UV, Naik DG. (2011). Cardiovascular-protective, antioxidative, and antimicrobial properties of natural thallus of lichen Usnea complanata. Lat Am J Pharm, 30, 220-228.
35. Molina MC, Crespo A, Vicente C, Elix JA. (2003). Differences in the composition of phenolics and fatty acids of cultured mycobiont thallus of Physconia distorta. Plant Phys Biochem, 41, 175-180.
36. Molnár K, Farkas E. (2010). Current results on biological activities of lichen secondary metabolites: A review. Z Naturforsch C J Biosci, 65, 157-173.
37. Müller K. (2001). Pharmaceutically relevant metabolites from lichens. Appl Microbiol Biotechnol, 56, 9-16.
38. Murashige T, Skoog F. 1962. A revised medium for rapid growth and bioassays with tobacco tissue cultures. Physiol Plant, 15, 473-497.
39. Nash TH. (1996). Lichen Biology. Cambridge: Cambridge University Press, 1-289.
40. Ondrejovic M, Ondrigova Z, Kubincova J. (2009). Isolation of antioxidants from Alchemilla xanthochlora. Nova Biotechnologica, 9, 313.
41. Roderick PJ, Wilkes HC, Meade TW. (1993). The gastrointestinal toxicity of aspirin: An overview of randomised controlled trials. Br J Clin Pharmacol, 35, 219-226.
42. Shukla V, Joshi GP, Rawat MSM. (2010). Lichens as a potential natural source of bioactive compounds: A review. Phytochem Rev, 9, 303-314.
43. Slinkard K, Singleton VL. (1977). Total phenol analysis: Automation and comparison with manual methods. Am J Enol Vitic, 28, 49-55.
44. Stocker-Worgotter E, Elix JA. 2004. Experimental studies of lichenized fungi: Formation of rare depsides and dibenzofurans by the cultured mycobiont of Bunodophoron patatgonicum (Spaerophoraceae, lichenized Ascomycota). Bibliotheca Lichenologica, 88, 659-669.
45. Stocker-Worgotter E, Hager A, Elix JA. (2009). Intraspecific chemical variation within the crustose lichen genus Haematomma: Anthraquinone production in selected cultured mycobionts as a response to stress and nutrient supply. Phytochem Rev, 8, 561-569.
46. Upreti DK, Chatterjee S. (2007). Significance of lichens and their secondary metabolites: A review. In: Ganguli BN, Deshmukh SK, eds. Fungi Multifaceted Microbes. New Delhi: Anamaya, 169-188.
47. Verma N, Behera BC, Makhija U. (2008). Antioxidant and hepatoprotective activity of a lichen Usnea ghattensis in vitro. Appl Biochem Biotechnol, 151, 167-181.
48. Yamamoto Y, Mizuguchi R, Yamada Y. 1985. Tissue cultures of Usnea rubescens and Ramallina yasudae and production of usnic acid in their cultures. Agric Biol Chem, 49, 3347-3348.
49. Yamamoto Y, Miura Y, Higuchi M, Kinoshita Y. (1993). Using lichen tissue cultures in modern biology. Bryologist, 96, 384-393.
50. Yoshimura I, Kinoshita Y, Yamamoto Y, Huneck S, Yamada Y. (1994). Analysis of secondary metabolites from lichen by high performance liquid chromatography with a photodiode array detector. Phytochem Anal, 5, 195-205.